The adenosine A 2a receptor belongs to the seven transmembrane helix G-protein-coupled receptor family, is abundant in striatum, vasculature and platelets and is involved in several physiological processes such as blood pressure regulation and protection of cells during anoxia. For structural and biophysical studies we have expressed the human adenosine A 2a receptor (hA2aR) at high levels inserted into the Escherichia coli inner membrane, and established a puri®cation scheme. Expression was in fusion with the periplasmic maltose-binding protein to levels of 10±20 nmol of receptor per L of culture, as detected with the speci®c antagonist ligand [ 3 H]ZM241385. As the receptor C-terminus was proteolyzed upon solubilization, a protease-resistant but still functional receptor was created by truncation to Ala316. Addition of the sterol, cholesteryl hemisuccinate, allowed a stable preparation of functional hA2aR solubilized in dodecylmaltoside to be obtained, and, increased the stability of the receptor solubilized in other alkylmaltosides. Puri®cation to homogeneity was achieved in three steps, including ligand a nity chromatography based on the antagonist xanthine amine congener. The puri®ed hA2aR fusion protein bound [ 3 H]ZM241385 with a K d of 0.19 nM and an average B max of 13.7 nmolámg )1 that suggests 100% functionality. Agonist a nities for the puri®ed solubilized receptor were higher than those for the membrane-bound form. Su cient pure, functional hA2aR can now be prepared regularly for structural studies. Adenosine is a paracrine modulator of cell function that is important for local regulatory processes in virtually all mammalian organs. Adenosine is involved in protection of cells during anoxia and is an ubiquitous neuromodulator in the central nervous system [1±4]. So far, four human adenosine receptors have been identi®ed (A 1 , A 2a , A 2b , and A 3 ) belonging to the family of G-protein-coupled receptors (GPCRs). Like many other GPCRs, adenosine receptors are potential drug targets. Drugs acting on the human adenosine A 2a receptor (hA2aR) are expected to have a therapeutic potential in CNS disorders, in¯ammation or stroke [5]. Mice lacking the adenosine A 2a receptor show increased aggression, hypoalgesia, faster platelet aggregation, high blood pressure and reduced exploratory activity indicating involvement of the receptor in a variety of physiological functions [6]. Direct structure determination of hA2aR by X-ray or electron crystallography, or information on the bound ligand conformation obtained by NMR spectroscopy, would assist in the design of subtype speci®c compounds and improve the understanding of GPCR function.GPCRs constitute a large protein family, but from the thousands of members, only rhodopsin has been puri®ed in large quantities from natural tissue. Functional heterologous expression and puri®cation of large quantities of GPCRs has proved to be very dif®cult [7±10]. Crystallization, NMR spectroscopy, and other work that depends on milligram quantities of puri®ed protein, are the...